ArticleJournal of the National Cancer Institute2015

Milestone Survival: A Potential Intermediate Endpoint for Immune Checkpoint Inhibitors.

Tai-Tsang ChenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.